TY - JOUR
T1 - Nutritional support in mitochondrial diseases: the state of the art
AU - Rinninella, Emanuele
AU - Pizzoferrato, Marco
AU - Servidei, Serenella
AU - Mele, Maria Cristina
PY - 2018
Y1 - 2018
N2 - Abstract. – Mitochondrial diseases are a group of rare multisystem disorders characterized by genetic heterogeneity and pleomorphic clinical manifestations. The clinical burden
may be heavy for patients and their caregivers. There are no therapies of proven efficacy until now and a multidisciplinary supportive care is therefore necessary. Since the common
pathogenic mechanism is the insufficient energy production by defective mitochondria, nutrition may play a crucial role. However, no guidelines are still available.
The article reports the current evidence, highlighting nutrition both as support and as therapy. The estimate of nutritional status, energy needs and nutritional behaviors are firstly
discussed. Then, we go in-depth on the scientific rationale and the clinical evidence of the use of anti-oxidants and enzyme-cofactors in the clinical practice. In particular, we analyze the
role of Coenzyme Q10, Creatine monohydrate, α-lipoic acid, riboflavin, arginine and citrulline, folinic acid, carnitine, vitamin C, K, and E. Every attempt at nutritional intervention
should be made knowing patient’s disease and focusing on his/her energy and nutrients’ requirements. For this reason, clinicians expert in mitochondrial medicine and clinical nutritionists
should work together to ameliorate care in these fragile patients.
AB - Abstract. – Mitochondrial diseases are a group of rare multisystem disorders characterized by genetic heterogeneity and pleomorphic clinical manifestations. The clinical burden
may be heavy for patients and their caregivers. There are no therapies of proven efficacy until now and a multidisciplinary supportive care is therefore necessary. Since the common
pathogenic mechanism is the insufficient energy production by defective mitochondria, nutrition may play a crucial role. However, no guidelines are still available.
The article reports the current evidence, highlighting nutrition both as support and as therapy. The estimate of nutritional status, energy needs and nutritional behaviors are firstly
discussed. Then, we go in-depth on the scientific rationale and the clinical evidence of the use of anti-oxidants and enzyme-cofactors in the clinical practice. In particular, we analyze the
role of Coenzyme Q10, Creatine monohydrate, α-lipoic acid, riboflavin, arginine and citrulline, folinic acid, carnitine, vitamin C, K, and E. Every attempt at nutritional intervention
should be made knowing patient’s disease and focusing on his/her energy and nutrients’ requirements. For this reason, clinicians expert in mitochondrial medicine and clinical nutritionists
should work together to ameliorate care in these fragile patients.
KW - personalised medicine, mitochondrial diseases
KW - personalised medicine, mitochondrial diseases
UR - http://hdl.handle.net/10807/124083
U2 - 10.26355/eurrev_201807_15425
DO - 10.26355/eurrev_201807_15425
M3 - Article
SN - 1128-3602
VL - 2018
SP - 4288
EP - 4298
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
ER -